These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
524 related items for PubMed ID: 17984937
1. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender. Zgliczynski W, Kochman M, Misiorowski W, Zdunowski P. Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937 [Abstract] [Full Text] [Related]
2. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients. Scillitani A, Chiodini I, Carnevale V, Giannatempo GM, Frusciante V, Villella M, Pileri M, Guglielmi G, Di Giorgio A, Modoni S, Fusilli S, Di Cerbo A, Liuzzi A. J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135 [Abstract] [Full Text] [Related]
3. Factors associated with bone metabolism in acromegalic patients: hypogonadism and female gender. Tütüncü NB, Erbaş T. Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):328-32. PubMed ID: 15216451 [Abstract] [Full Text] [Related]
4. Bone mineral density of the axial skeleton in acromegaly. Ho PJ, Fig LM, Barkan AL, Shapiro B. J Nucl Med; 1992 Sep; 33(9):1608-12. PubMed ID: 1517833 [Abstract] [Full Text] [Related]
5. Circulating cytokines in relation to bone mineral density changes in patients with acromegaly. Bolanowski M, Daroszewski J, Zatonska K, Arkowska A. Neuro Endocrinol Lett; 2006 Sep; 27(1-2):183-8. PubMed ID: 16648806 [Abstract] [Full Text] [Related]
6. Bone mineral density and parameters of bone metabolism in patients with acromegaly. Kotzmann H, Bernecker P, Hübsch P, Pietschmann P, Woloszczuk W, Svoboda T, Geyer G, Luger A. J Bone Miner Res; 1993 Apr; 8(4):459-65. PubMed ID: 8475795 [Abstract] [Full Text] [Related]
7. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia. Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M. Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524 [Abstract] [Full Text] [Related]
8. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood. Brennan BM, Rahim A, Adams JA, Eden OB, Shalet SM. Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305 [Abstract] [Full Text] [Related]
9. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist? Hitz MF, Jensen JE, Eskildsen PC. Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531 [Abstract] [Full Text] [Related]
10. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines. Street ME, Spaggiari C, Ziveri MA, Volta C, Federico G, Baroncelli GI, Bernasconi S, Saggese G. Horm Res; 2006 Dec; 66(4):162-8. PubMed ID: 16804317 [Abstract] [Full Text] [Related]
11. The clinical significance of bone mineral density and testosterone levels in Korean men with non-mosaic Klinefelter's syndrome. Seo JT, Lee JS, Oh TH, Joo KJ. BJU Int; 2007 Jan; 99(1):141-6. PubMed ID: 17092285 [Abstract] [Full Text] [Related]
12. IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men. Rucker D, Ezzat S, Diamandi A, Khosravi J, Hanley DA. Clin Endocrinol (Oxf); 2004 Apr; 60(4):491-9. PubMed ID: 15049965 [Abstract] [Full Text] [Related]
13. Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study. Battista C, Chiodini I, Muscarella S, Guglielmi G, Mascia ML, Carnevale V, Scillitani A. Clin Endocrinol (Oxf); 2009 Mar; 70(3):378-82. PubMed ID: 18616713 [Abstract] [Full Text] [Related]
14. Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients. Ueland T, Fougner SL, Godang K, Schreiner T, Bollerslev J. Eur J Endocrinol; 2006 Nov; 155(5):709-15. PubMed ID: 17062887 [Abstract] [Full Text] [Related]
15. Gonadal status is an important determinant of bone density in acromegaly. Lesse GP, Fraser WD, Farquharson R, Hipkin L, Vora JP. Clin Endocrinol (Oxf); 1998 Jan; 48(1):59-65. PubMed ID: 9509069 [Abstract] [Full Text] [Related]
16. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis. Lormeau C, Soudan B, d'Herbomez M, Pigny P, Duquesnoy B, Cortet B. Bone; 2004 Jun; 34(6):933-9. PubMed ID: 15193539 [Abstract] [Full Text] [Related]
17. Endocrine and physical determinants of bone mass in late postmenopause. Albanese CV, Civitelli R, Tibollo FG, Masciangelo R, Mango D. Exp Clin Endocrinol Diabetes; 1996 Jun; 104(3):263-70. PubMed ID: 8817245 [Abstract] [Full Text] [Related]
18. Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men. Rhee EJ, Oh KW, Lee WY, Kim SW, Oh ES, Baek KH, Kang MI, Park CY, Choi MG, Yoo HJ, Park SW. J Bone Miner Metab; 2004 Jun; 22(4):392-8. PubMed ID: 15221500 [Abstract] [Full Text] [Related]
19. Bone mineral density and menstrual irregularities. A comparative study on cortical and trabecular bone structures in runners with alleged normal eating behavior. Tomten SE, Falch JA, Birkeland KI, Hemmersbach P, Høstmark AT. Int J Sports Med; 1998 Feb; 19(2):92-7. PubMed ID: 9562216 [Abstract] [Full Text] [Related]
20. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Sowers MR, Finkelstein JS, Ettinger B, Bondarenko I, Neer RM, Cauley JA, Sherman S, Greendale GA, Study of Women's Health Across the Nation. Osteoporos Int; 2003 Jan; 14(1):44-52. PubMed ID: 12577184 [Abstract] [Full Text] [Related] Page: [Next] [New Search]